Pranav Radhakrishnan is a Director with global pharmaceutical company, Novartis. He is an expert in the field of Operational Excellence and Lean Six Sigma. At Novartis he is spearheading strategy and operations across 8 brands, with an annual P&L budget of $45M+, prioritizing and approving strategic projects using commercial insights across each brand to increase quarter to quarter financial growth and patient engagement.
Prior to Novartis, he was a global principal at Bayer where he conceptualized and executed digital twin creation for efficient operations management, which is future oriented, industry-first simulation capabilities to identify gaps and opportunities across multiple assets with next generation dashboards and delivering strategic deliverables. He led 6 drug launches (Mayzent, Beovu, Kesimpta, Leqvio, Lutathera and Pluvicto) by coordinating with brand management and vendors to design and execute patient access frameworks with improved operational efficiency to impact revenue by over $1 billion.